日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mesenchymal stromal cell therapy for post-COVID-19 syndrome: associated impact and mechanism

间充质干细胞疗法治疗新冠肺炎后遗症:相关影响及机制

Pan, Yuefei; Yuan, Mengqi; Song, Le; Yao, Weiqi; He, Junli; Mo, Qiong; Zheng, Ning; Zhang, Ziying; Dong, Tengyun; Zhu, Kaidi; Zhang, Zeyi; Xiong, Jiaqi; Dong, Jinghui; Zhang, Jianzeng; Zhang, Mengmeng; Zhang, Chao; Li, Yuanyuan; Liu, Limin; Li, Jing; Xie, Yunbo; Shi, Ming; Huang, Lei; Xu, Zhe; Zhang, Yu; Zhang, Bo; Shi, Lei; Wang, Fu-Sheng

Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights

间充质干细胞治疗失代偿期肝硬化的剂量递增研究:Ia/Ib期结果及免疫调节见解

Shi, Lei; Zhang, Ziying; Mei, Song; Wang, Zerui; Xu, Zhe; Yao, Weiqi; Liu, Limin; Yuan, Mengqi; Pan, Yuefei; Zhu, Kaidi; Liu, Kai; Meng, Fanglin; Sun, Jiao; Liu, Wenying; Xie, Xiaohui; Dong, Tengyun; Huang, Lei; Meng, Fanping; Fu, Jun-Liang; Li, Yuanyuan; Zhang, Chao; Fan, Xing; Shi, Ming; Zhang, Yu; Li, Yonggang; Xie, Wei-Fen; Zhang, Peng; Wang, Fu-Sheng

Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0

慢性乙型肝炎功能性治愈治疗导航最新进展:专家共识 2.0

Wu, Di; Kao, Jia-Horng; Piratvisuth, Teerha; Wang, Xiaojing; Kennedy, Patrick T F; Otsuka, Motoyuki; Ahn, Sang Hoon; Tanaka, Yasuhito; Wang, Guiqiang; Yuan, Zhenghong; Li, Wenhui; Lim, Young-Suk; Niu, Junqi; Lu, Fengmin; Zhang, Wenhong; Gao, Zhiliang; Kaewdech, Apichat; Han, Meifang; Yan, Weiming; Ren, Hong; Hu, Peng; Shu, Sainan; Kwo, Paul Yien; Wang, Fu-Sheng; Yuen, Man-Fung; Ning, Qin

Multi-omics dissection of metabolic dysregulation associated with immune recovery in people living with HIV-1

利用多组学方法解析 HIV-1 感染者免疫恢复相关的代谢紊乱

Wan, Lin-Yu; Lam, Sin Man; Huang, Hui-Huang; Cao, Wen-Jing; Cao, Xiang-Yi; Li, Xue-Meng; Zhang, Li-Ping; Gao, Jia-Min; Zhang, Chao; Fan, Xing; Jiao, Yan-Mei; Shui, Guanghou; Wang, Fu-Sheng; Song, Jin-Wen

Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial

间充质干细胞疗法治疗重症 COVID-19 患者的长期疗效:一项随机、双盲、安慰剂对照试验的 3 年随访结果

Yuan, Meng-Qi; Song, Le; Wang, Ze-Rui; Zhang, Zi-Ying; Shi, Ming; He, Junli; Mo, Qiong; Zheng, Ning; Yao, Wei-Qi; Zhang, Yu; Dong, Tengyun; Li, Yuanyuan; Zhang, Chao; Song, Jinwen; Huang, Lei; Xu, Zhe; Yuan, Xin; Fu, Jun-Liang; Zhen, Cheng; Cai, Jianming; Dong, Jinghui; Zhang, Jianzeng; Xie, Wei-Fen; Li, Yonggang; Zhang, Bo; Shi, Lei; Wang, Fu-Sheng

Efficacy and safety of mesenchymal stem/stromal cells and their derived extracellular vesicles for acute respiratory distress syndrome: a systematic review and meta-analysis

间充质干/基质细胞及其衍生的细胞外囊泡治疗急性呼吸窘迫综合征的疗效和安全性:系统评价和荟萃分析

Wu, Yaxin; Xu, Ruonan; Li, Yuanyuan; Liu, Kai; Yang, Tao; Shi, Ming; Wang, Fu-Sheng; Xu, Zhe

Safety and efficacy of human umbilical cord-derived mesenchymal stem cells in COVID-19 patients: A real-world observation

人脐带间充质干细胞治疗新冠肺炎患者的安全性和有效性:一项真实世界观察研究

Wang, Siyu; Yang, Tao; Li, Tiantian; Shi, Lei; Xu, Ruonan; Zhang, Chao; Wang, Zerui; Zhang, Ziying; Shi, Ming; Xu, Zhe; Wang, Fu-Sheng

Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysis

新型抗病毒疗法治疗乙型肝炎病毒的功能性治愈:系统评价和荟萃分析

Chen, Jing; Ji, Dong; Jia, Jidong; Zhuang, Hui; Zhang, Xinxin; Wang, Fu-Sheng; Zhang, Wenhong; Dou, Xiaoguang; Tanwandee, Tawesak; Sarin, Shiv Kumar; Maiwall, Rakhi; Kumar, Manoj; Goh, George Boon-Bee; Ghazinyan, Hasmik; Chutaputti, Anuchit; Chen, Pei-Jer; You, Hong; Yu, Ming-Lung; George, Jacob; Omata, Masao; Wang, Gui-Qiang; Lau, George

Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: a retrospective cohort study

PD-1抑制剂联合酪氨酸激酶抑制剂治疗晚期肝细胞癌合并高胆红素血症患者的安全性和有效性:一项回顾性队列研究

Pan, Shida; Wang, Jianing; Tian, Jiahe; Wang, Yilin; Wang, Siyu; Yu, Yingying; Li, Fengyi; Jiao, Yan-Mei; Shen, Yingjuan; Yang, Luo; Liu, Xiaomeng; Qiu, Qin; Luan, Junqing; Wang, Fu-Sheng; Meng, Fanping

MicroRNA-126-3p as a predictive biomarker for patients with primary biliary cholangitis refractory to ursodeoxycholic acid.

MicroRNA-126-3p 作为对熊去氧胆酸治疗无效的原发性胆汁性胆管炎患者的预测生物标志物

Pan Shi-Da, Xiong Chu-Yue, Shen Ying-Juan, Tian Jia-He, Wang Yi-Lin, Wang Jia-Ning, Wang Si-Yu, Li Feng-Yi, Wang Li-Feng, Qiu Qin, Yang Luo, Liu Xiao-Meng, Luan Jun-Qing, Zou Zheng-Sheng, Wang Fu-Sheng, Meng Fan-Ping